Telix Pharmaceuticals Graham Net Net Over Time

TLX Stock   15.35  0.20  1.32%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Telix Pharmaceuticals Performance and Telix Pharmaceuticals Correlation.
  
Graham Net Net is likely to drop to -1.12 in 2024.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Telix Pharmaceuticals. If investors know Telix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Telix Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.1
Revenue Per Share
1.991
Quarterly Revenue Growth
0.581
Return On Assets
0.0797
Return On Equity
0.2049
The market value of Telix Pharmaceuticals is measured differently than its book value, which is the value of Telix that is recorded on the company's balance sheet. Investors also form their own opinion of Telix Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Telix Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Telix Pharmaceuticals' market value can be influenced by many factors that don't directly affect Telix Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Telix Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Telix Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Telix Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Graham Net Net Analysis

Compare Telix Pharmaceuticals and related stocks such as Vigil Neuroscience, Vincerx Pharma, and Viracta Therapeutics Graham Net Net Over Time
Select Fundamental
Price To Sales RatioPtb Ratio
Days Sales OutstandingBook Value Per Share
Free Cash Flow YieldInvested Capital
Operating Cash Flow Per ShareAverage Payables
Stock Based Compensation To RevenueCapex To Depreciation
Pb RatioEv To Sales
Free Cash Flow Per ShareRoic
Inventory TurnoverNet Income Per Share
Days Of Inventory On HandPayables Turnover
Sales General And Administrative To RevenueAverage Inventory
Research And Ddevelopement To RevenueCapex To Revenue
Cash Per SharePocfratio
Interest CoveragePayout Ratio
Capex To Operating Cash FlowPfcf Ratio
Days Payables OutstandingNet Current Asset Value
Income QualityRoe
Tangible Asset ValueEv To Operating Cash Flow
Pe RatioReturn On Tangible Assets
Ev To Free Cash FlowIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Dividend YieldEarnings Yield
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
201020112012201320142015201620172018201920202021202220232024
VIGL(1.0412)(1.0412)(1.0412)(1.0412)(1.0412)(1.0412)(1.0412)(1.0412)(1.0412)(1.0412)(1.0412)(52.533)5.69892.43972.56
VINC0.12330.12330.12330.12330.12330.12330.12330.12330.12330.12334.0255.47881.96160.27180.26
VIRX50333.955812.6702(8.5161)12.525177.227445.463527.0682.326310.0137(511)2.80431.47390.40030.38
VNDA0.03070.037(0.15)1.08443.57341.81.79261.8664.37944.88685.70886.63956.82835.42045.69
KTTAW0.34410.34410.34410.34410.34410.34410.34410.34410.34410.34410.344144.389624.133810.786615.93
VRCA(0.1344)(0.1344)(0.1344)(0.1344)(0.1344)(0.1344)(0.1344)0.403411.38052.35390.97230.84430.86950.25440.24
VRNA0.02980.01190.00324.0E-40.01360.0020.01660.87030.55612.07385.38842.0883.13062.78992.93
VSTM(14.2286)(14.2286)34.685749.518139.320961.803222.618617.041816.8103(9.4813)8.00867.44182.49473.03212.88
VTGN(240)(240)(424)(328)(475)(60.0448)(0.6975)12.99486.8313(6.9387)30.40879.00611.04345.673(0.0714)

Telix Pharmaceuticals and related stocks such as Vigil Neuroscience, Vincerx Pharma, and Viracta Therapeutics Graham Net Net description

My Equities

My Current Equities and Potential Positions

Telix Pharmaceuticals Limited
TLX
Specialization
Healthcare, Biotechnology
LocationAustralia
ExchangeNASDAQ Exchange
null 15.35

Additional Tools for Telix Stock Analysis

When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.